The formation of the business came during initial research into radiation sickness which led to the creation of a genetically engineered compound to retard its effects known as Hydronilen. Amongst the test subjects for the compound, over 90% of subjects experienced remission in their symptoms. In later years, Bio/Genetic Research began experimenting with creating genetically tailored micro-organisms used for the creation of new synthetic compounds for agricultural, medicinal and industrial needs.
Attributes | Values |
---|---|
rdfs:label |
|
rdfs:comment |
|
dcterms:subject | |
dbkwik:memory-beta...iPageUsesTemplate | |
abstract |
|